OPEN Foundation

Survey: Quit smoking after a psychedelic experience?

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Researchers from the Johns Hopkins University School of Medicine are currently recruiting individuals who have quit smoking cigarettes or reduced their smoking (even temporarily) after an experience with a psychedelic, for participation in an online survey. Their team has previously conducted innovative research on the effects of compounds including psilocybin, dextromethorphan, and salvinorin A.

The goal of this survey is to learn more about whether psychedelic drugs are associated with reduction or cessation of cigarette smoking. The researchers want to characterize people’s experiences in non-­laboratory settings in which taking a psychedelic may have led to reducing or quitting smoking. For the purposes of this survey, the survey will be asking specifically about individuals who have quit smoking cigarettes or reduced their smoking (even temporarily) after experiences with psilocybin (magic) mushrooms, LSD, morning glory seeds, mescaline, peyote cactus, San Pedro cactus, DMT, or ayahuasca. This research study has been approved by the Institutional Review Board of Johns Hopkins Medicine.

The survey is completely anonymous (IP addresses will not be recorded) and will require 40-45 minutes to complete. If you are interested in participating, please click this link. Participation is voluntary and will not be financially compensated.

Participants must be 18+ years of age, speak/write English fluently, and have experienced a reduction or cessation of cigarette smoking after an experience with one of the psychedelic substances listed above. For more information, please contact the researchers via the site’s private messaging system.

Principal Investigator of this study, Matthew W. Johnson was a speaker at our Interdisciplinary Conference on Psychedelic Research in 2012. A video on the topic of this study can be watched below.

OPEN Foundation

Join ICPR 2022 Online!

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. Get your ICPR 2022 livestream ticket today and use the code OPENLIVE30 at checkout for a €30 discount.

Learn More

INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?

Subscribe to our new OPEN-Minded newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

2 April - New Insights on Addiction & Psychedelic Healing Followed by a Live Q&A!

X